Super Religare Laboratories Limited (Formerly SRL Ranbaxy Ltd.) is one of the leading pathology laboratory network in India, servicing nearly 1550 hospitals/path labs and over 50,000 doctors. SRL along with its subsidiary SRL Diagnostics private Limited performs over 33,000 tests/day and catered to approximately 4.20 million customers during the nine month period ended December 31, 2010, offering a comprehensive range of over 3,300 diagnostic tests, from the routine to the highly specialized tests.
Through our network of reference laboratories within and outside India, network laboratories, collection centers and representation offices and liaison offices, we are able to provide routine and specialized testing services to customers outside India, including leading hospital chains in the United Arab Emirates, Oman, Qatar, Kuwait, Bahrain, Sri Lanka, Bangladesh, Nepal, the Maldives, Tanzania and Zambia.
Super Religare Laboratories Limited (Formerly SRL Ranbaxy Ltd.) strives to strengthen
its analytical capability and take its services beyond providing just an inert report
by taking following steps: developing predictive and preventive capabilities; providing
advanced analytical support for better health management; taking Wellness beyond
physical health by focusing on lifestyle value adds such as emotional wellbeing.
Clinical Research Services Division is dedicated to offering Central Laboratory
Services to support the needs of drug development for various Phases of Clinical
Trials. It's a force offering Central Laboratory Services with an uniquely flexible
approach in customizing our services to comply with the protocol requirements and
the needs of our Sponsors with a commitment of accuracy and reproducibility of our
analytical data.
To successfully implement the discoveries and technological advancements in the field of healthcare and diagnostics business segment, effective means and tools for knowledge creation and dissemination are most essential. Knowledge Management team of R&D is actively involved in creatively inventing the tools for knowledge dissemination through focused and intense literary research. The motto of this initiative is “Achieve Better Health through Knowledge Awareness”.
As part of this initiative a monthly Newsletter and email detailer are published and circulated to our valued customers.
The Newsletter titled "Innersense"focuses on various disease segments and highlights the new concepts and diagnostic modalities. It also provides an overview of improvement and up gradation of technology and applications, emerging therapeutic strategies and startling research findings on the International front.
The
email detailer titled “Medimail” focuses on
in depth information relating to sensitivity, specificity,
technological advantages, clinical utility and other aspects
of diagnostic, prognostic or monitoring tools.
In the
scientific, technical and medical fields, publication is an
integral part of the research process. Faculties and students
at SRL R&D are actively involved in frontline Biomedical
Research.
Won prestigious FICCI Healthcare Excellence Award for Operational Excellence in Healthcare Delivery in 2010.
•
Received Frost & Sullivan Award in 2007 and 2009 in the recognition of being the Diagnostics Company for the respective years.
•
As of December 31, 2010, SRL, along with its subsidiary SRL Diagnostics private Limited runs eight reference laboratories, seven Centers of Excellence, 181 network laboratories (comprising 164 pathology laboratories and 17 radiology laboratories), 15 wellness centers and 888 collection centers.
•
Serving approximately 4.20 million customers during the nine month period ended December 31, 2010 and counting...
